Lymphoma: Comparing Pneumococcal Vaccines

We are studying the effectiveness of two pneumococcal vaccines in adults with lymphoma receiving chemotherapy. This trial aims to see which vaccination strategy provides a better immune response and is safer.

>2 yearsMonitoring phase (IV)No PlaceboStandard MedicinesInjectionInfectious DiseasesOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Pneumovax
Pneumovax is a vaccine that helps prevent pneumonia and other infections caused by pneumococcal bacteria.
Pneumovax 23
Pneumovax 23 is a vaccine that helps protect adults and some children from pneumonia and other serious infections caused by pneumococcal bacteria.
Prevenar 13
Prevenar 13 is a vaccine that helps protect infants, children, and adults from serious infections like pneumonia, meningitis, and ear infections caused by bacteria.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Pneumococcal Polysaccharide Serotype 1
Pneumococcal polysaccharide serotype 1 is a vaccine component that helps the immune system prevent infections caused by pneumococcus serotype 1.
Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
Pneumococcal polysaccharide serotype 1 conjugated to CRM197 adsorbed on aluminium phosphate is a vaccine component that helps protect against pneumococcal serotype 1 infections.
Pneumococcal Polysaccharide Serotype 10a
Pneumococcal polysaccharide serotype 10A is a vaccine ingredient that helps the immune system protect against pneumonia-causing bacteria of serotype 10A.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Pneumovax®
Pneumovax®
Пневмовакс 23

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Regional D'Angers
Service des Maladies du sang
Angers, France
Centre Hospitalier Universitaire De Bordeaux
Service d'hématologie et de thérapie cellulaire
Canéjan, France
Centre Hospitalier Et Universitaire De Limoges
Service d'oncologie hématologie et thérapie cellulaire
Isle, France
Sponsor: Centre Hospitalier Universitaire De Poitiers
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.